BioNTech SE
113.74
1.31 (1.17%)
At close: Jan 15, 2025, 11:46 AM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income 1.19B 12.95B 15.05B -145.80M -179.44M -47.66M -85.91M
Depreciation & Amortization 183.40M 123.30M 75.20M 38.74M 33.90M 21.98M 10.53M
Stock-Based Compensation 51.40M 108.60M 93.90M 32.10M 30.23M 7.64M 5.91M
Other Working Capital n/a -50.87M n/a n/a n/a n/a n/a
Other Non-Cash Items -1.62B -4.13B 212.50M 114.47M 262.00K -226.00K -1.40M
Deferred Income Tax n/a n/a -3.79B 40.06M -54.00K 1.04M 26.27M
Change in Working Capital 5.57B 4.52B -10.73B -93.10M -83.44M -40.96M -7.96M
Operating Cash Flow 5.37B 13.58B 889.70M -13.47M -198.54M -58.18M -52.56M
Capital Expenditures -705.50M -363.30M -154.00M -85.45M -71.08M -67.85M -57.74M
Acquisitions -336.90M 589.19K -20.80M -60.64M -6.06M 727.57K 4.88M
Purchase of Investments -7.13B -47.80M -394.70M n/a n/a n/a n/a
Sales Maturities Of Investments 1.22B 375.20M 26.50M n/a n/a n/a n/a
Other Investing Acitivies -455.40M 10.81K -23.10M 1.24M 21.00K 706.00K 5.19M
Investing Cash Flow -6.95B -35.30M -566.10M -144.85M -77.11M -67.15M -52.55M
Debt Repayment -40.10M -59.10M -66.70M 141.70M 7.90M 3.45M -1.64M
Common Stock Repurchased -738.50M -986.40M n/a n/a n/a n/a n/a
Dividend Paid n/a -475.58M n/a n/a n/a n/a n/a
Other Financial Acitivies n/a n/a n/a n/a n/a n/a n/a
Financial Cash Flow -778.60M -1.42B 94.20M 894.73M 383.29M 365.18M -1.64M
Net Cash Flow -2.21B 12.18B 482.50M 691.06M 107.65M 239.39M -131.57M
Free Cash Flow 4.67B 13.21B 735.70M -98.92M -269.62M -126.03M -110.30M

Create Price Alert on BNTX

Your price alert will notify you when the stock price is above 113.74.

Add to Watchlist